Skip to content

SYBEPHAR

Active Private limited companyfounded 1992active for 33 yearsBeverestraat 50, 9700 OudenaardeKBO/BCE: BE 0448.892.046

Lifetime

20 annual accounts with figures on one time axis, 33 filings since 1993
peak of €399,968 in 2025
€399,968▲ 22.9%
lowest -€37,415 in 2018
€148,100▲ 41.0%
peak of €416,182 in 2025
€416,182▲ 29.4%
€554,234▲ 14.8%
peak of 1.3 FTE in 2025
1.3 FTE▲ 30.0%
Board2 names since 2021
1 director
Documentsfilings and deeds
03-06-202658 days before the deadline
2025abbreviated format
Gross margin from €325,370 to €399,968Result from €105,049 to €148,100Staff from 1 FTE to 1.3 FTEDividend €53,423Equity from €321,506 to €416,182Cash from €117,155 to €181,284

Key points

from the 2025 annual accounts

Equity

€416,182 ▲ 29.4%
321,5062024+148,100Profit-53,423Dividend416,1822025

SYBEPHAR paid out €53,423 in dividends. That is 36% of the 2025 profit.

Staff

2 employees on 31-12-2025
112024102025

In 2025, 1 employee joined and nobody left.

Filings

33 annual accounts since 1993
AprilJune31 JulyOctober200020102020

Four of the last ten came late. The 2019 accounts came in latest, 61 days after the end of the period.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 31,389 companies had the same profile as SYBEPHAR has now. Each dot stands for 79 companies, two years later.

93.4%
were still trading
6.0%
stopped another way
0.5%
went bankrupt
  • Micro
  • 20 years or older
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more

Another 0.1% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,965 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 31,389 companies, not a prediction for SYBEPHAR. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0448892046
resigns as director Gazette deed
(director) and (director) change roles “De uitbating van één of meer apotheken; De groot- en kleinhandel in,alsmede de bereiding van…” (deed in Dutch) · Gazette deed
Capital increase · Amendment of the articles The capital rose from €49,578.70 to €144,474.82, with 3,828 new shares · The capital rose from €144,474.82 to €175,578.70 · Gazette deed
All 46 events

Comparable companies

same main activity, similar in size and age
Company
SYBEPHAR Oudenaarde €1.0m €399,968 42.9% 1.3
Apotheek Dreesen Bree €1.1m €400,073 43.5% 1.4
PHARMACIE KINDT Comines-Warneton €1.0m €350,026 45.7% 1.2
APOTHEEK PROOSTERBOS Maasmechelen €1.1m €458,885 18.1% 1.5
PHARMA LINK Lichtervelde €1.0m €335,992 14.6% 1.5
APOTHEEK GEERT VANDERHEYDEN Maaseik €1.1m €343,372 19.0% 1.7
APOTHEEK DE GROOTE-CROUBELS Kaprijke €1.1m €313,702 81.6% 1.1

These companies have the same main activity as SYBEPHAR: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €1m and €1.1m, founded between 1991 and 1998.

Official details

Source: KBO
Status
Active since 10-12-1992Normal situation
Activity
Retail sale of pharmaceutical productsNACE 47730
Joint committee
313Pharmacies and pricing offices · annual accounts 2025
Establishment unit
2.060.955.2389700 Oudenaarde, since 02-03-1993
Financial year end
31 December
Peppol
Reachable since 30-10-2025
Company details

Annual accounts 2025

≈ €1.4mestimated
€970,416▲ 20.7%
Employeeson 31-12-2025
2▲ 100%
Filing
Filed on 03-06-2026, 58 days before the end of the filing period
Financials

Insights on SYBEPHAR

SYBEPHAR files the abbreviated format. That format states no turnover. The gross margin rose from €89,465 in 2006 to €399,968 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about SYBEPHAR

What is the company number of SYBEPHAR?
The company number of SYBEPHAR is 0448.892.046. The VAT number is the same number with BE in front: BE 0448.892.046.
Where is SYBEPHAR based?
The registered office is at Beverestraat 50, 9700 Oudenaarde.Company details
What does SYBEPHAR do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of SYBEPHAR?
SYBEPHAR is a private limited company (BV).
When was SYBEPHAR founded?
SYBEPHAR was founded on 10-12-1992.
Is SYBEPHAR still active?
Yes, SYBEPHAR is an active enterprise in the KBO register.
How many employees does SYBEPHAR have?
SYBEPHAR had an average of 1.3 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
Which joint committee does SYBEPHAR fall under?
In its 2025 annual accounts, SYBEPHAR states joint committee 313 (Pharmacies and pricing offices).
What is the turnover of SYBEPHAR?
The turnover in financial year 2025 is ≈ €1.4m. This figure is estimated from the gross margin of €399,968 and 42 comparable companies (NACE 477). It probably lies between €1.1m and €1.9m.
Is SYBEPHAR profitable?
In financial year 2025, SYBEPHAR made a profit of €148,100.
Where can I find the annual accounts of SYBEPHAR?
SYBEPHAR filed 33 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of SYBEPHAR due?
SYBEPHAR must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.